MYP_049925
Basic Information
P109, GBV-C E2 (325-342)
Antimicrobial
Antiviral
Antiviral Anti-HIV
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Standard
18 amino acids
C99H152N24O25
Standard
Sequence
LQEVDAGNFIPPPRWLLL
Physicochemical Analysis
2078.41 Da
4.37
-1.24
-1.44
-0.0687
0.22
0.32
0.24
71.13
130.00
0.1111
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
770.12
-2.59
24.0
24.0
61.0
148.0
6.0
19.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0365007 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1
37.5 μM
IC50
Mammalian: 5.5 h; Yeast: 3 min; E. coli: 2 min
RECORD: Rec_0405411 VERIFIED: YES
Provenance & Taxonomy
GB virus C [Virus]
54290
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Fusion inhibitor
CEM-174
20 %
Inhibition
Showing 2 records on this page · Page 3 of 3